|
SRP54 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.82460000003526E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.91730000343694E-08 |
| Normal-vs-Stage2 |
4.807900E-04 |
| Normal-vs-Stage3 |
1.168030E-01 |
| Normal-vs-Stage4 |
3.753300E-04 |
| Stage1-vs-Stage2 |
8.565400E-01 |
| Stage1-vs-Stage3 |
7.530300E-02 |
| Stage1-vs-Stage4 |
8.569800E-01 |
| Stage2-vs-Stage3 |
2.871800E-01 |
| Stage2-vs-Stage4 |
7.445400E-01 |
| Stage3-vs-Stage4 |
1.647220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.64490000012607E-07 |
| Normal-vs-AfricanAmerican |
3.76420000000044E-05 |
| Normal-vs-Asian |
6.772800E-01 |
| Caucasian-vs-AfricanAmerican |
8.013200E-01 |
| Caucasian-vs-Asian |
2.769000E-01 |
| AfricanAmerican-vs-Asian |
5.323400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.96779994707941E-09 |
| Normal-vs-Female |
6.352000E-02 |
| Male-vs-Female |
1.017900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.384800E-04 |
| Normal-vs-Extreme_Weight |
1.42280000003936E-08 |
| Normal-vs-Obese |
2.202000E-03 |
| Normal-vs-Extreme_Obese |
1.244480E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.329400E-01 |
| Normal_Weight-vs-Obese |
4.012800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.907000E-01 |
| Extreme_Weight-vs-Obese |
4.832200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.171000E-01 |
| Obese-vs-Extreme_Obese |
2.672800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.785000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.47069999999017E-05 |
| Normal-vs-Age(61-80Yrs) |
7.92739995869596E-09 |
| Normal-vs-Age(81-100Yrs) |
4.239700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.661700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.224400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.835900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.749700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.890000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.864800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.51280000140852E-08 |
| Normal-VS-Type2 PRCC |
4.08149999999718E-05 |
| Normal-VS-KIRP CIMP |
6.003800E-01 |
| Normal-VS-Unclassified PRCC |
7.561000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.717000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.743900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.160600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.122240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.689400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.125010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36040000001214E-06 |
| Normal-vs-N1 |
5.132400E-01 |
| Normal-vs-N2 |
4.25760000000164E-05 |
| N0-vs-N1 |
3.956400E-02 |
| N0-vs-N2 |
1.441950E-01 |
| N1-vs-N2 |
6.003800E-02 |
|
|
